- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
San Ramon Today
By the People, for the People
Cooper Companies and Becton, Dickinson Compete in Medical Device Market
Analysts weigh the pros and cons of these two major healthcare players
Apr. 11, 2026 at 8:20pm
Got story updates? Submit your updates here. ›
A refined, conceptual still life captures the competitive landscape of the medical device market.San Ramon TodayCooper Companies (NASDAQ:COO) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical device companies, but which one is the better investment? The two firms were analyzed and compared across factors like analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation, and risk.
Why it matters
As major players in the lucrative medical device industry, the performance and outlook of Cooper Companies and Becton, Dickinson are closely watched by investors. Understanding the relative strengths and weaknesses of these two competitors can help inform investment decisions in the healthcare sector.
The details
The analysis found that Cooper Companies has a stronger consensus rating from analysts and a higher potential upside, suggesting it is viewed more favorably. Cooper also has higher profitability metrics and more institutional ownership. However, Becton, Dickinson has lower stock price volatility. The two companies operate in different medical device segments, with Cooper focused on contact lenses and women's health, while Becton, Dickinson has a broader portfolio spanning drug delivery, lab equipment, and interventional products.
- The analysis was published on April 11, 2026.
The players
Cooper Companies
A large-cap medical device company that develops, manufactures, and markets contact lenses and women's healthcare products.
Becton, Dickinson and Company
A large-cap medical device and diagnostics company that produces a wide range of products including drug delivery systems, lab equipment, and interventional devices.
The takeaway
The analysis highlights the competitive dynamics in the medical device industry, with two major players offering different product portfolios and financial profiles. Investors will need to weigh the relative merits of each company's strengths to determine the better long-term investment.
